Flexibility by Design
Morten Munk NNE
February 27 - March 2, 2017 San Francisco, CA
Design February 27 - March 2, 2017 San Francisco, CA TRENDS A - - PowerPoint PPT Presentation
Morten Munk NNE Flexibility by Design February 27 - March 2, 2017 San Francisco, CA TRENDS A LITTLE QUIZ 2 Trends Multi product - flexible facilities Hybrid facilities 2- 8 times 15K SS 2- 8 times 2K SUS SS and SUS
February 27 - March 2, 2017 San Francisco, CA
2
3
4
Level 1 Real-time automatic control + Flexible process parameters to respond to the variability in the input material attributes Level 2 Reduced end product testing + Flexible critical material attributes and critical process parameters within design space Level 3 End product testing + tightly constrained material attributes and process parameters5
6
12th Annual report and survey of biopharmaceutical manufacturing capacity and production
Eric S. Langer, MS, President, BioPlan Associates, Inc.
Orphan drugs catch fire in big pharma PM360 July 2015
7
Focus on manufacturing Speed Focus on change-over speed Last century product distribution
8
Today’s product distribution
China has a robot density of just 36 – but they aim for a density of 150 by 2020 An increase of 600,000 industrial robots by 2020 Robot sales was globally 254,000 in 2015
Source IFR: World robotics 2016
Robots/10,000 employees
10
11
1. Get all product produced at CMO’s 2. Co-invest in construction of new facilities together with a CMO 3. Build own facility covering all or a portion
NPV
Total investment cost TIC Internal cost Facility and project staff Qualification Raw Materials Utilities IT Cost of incorporating flexibility and cost of lack of flexibility Project schedule Timeline from decision to approval Plant productivity Utilization Change-over time Contingencies The known unknowns Project changes Cost of capital Risk of product not being approved for the market Lost revenues from delayed market entrance Future revenues from sales
12
13
Batch size
Product demand
Normal distribution
14
Batch size Product demand
15
Orphan drug Insulin
Batch size Product demand
16
Luxemburg USA
Batch size Product demand
17
Process level flexibility Operations flexibility Suite configuration flexibility Site and integration flexibility Investment flexibility
18
19
20
21
22
23
1 2 3 4 5 6
1. Basic production process structure.
24
25
Support systems installation Process systems installation Process systems installation Process systems installation
26
27
STAINLESS STEEL SINGLE USE 350 L 1000 L CIP/SIP
TRADITIONAL STAINLESS STEEL GUY THE PRAGMATIC GUY SINGLE USE TECHNOLOGY GUY
28
Stainless steel Single Use Scale Capital – investment – CAPEX Capital – operational costs – OPEX Minimise risk of (cross) contamination Time for establishing a facility Flexibility Change over time Commission and qualification Leachables Ease to tech transfer Sustainability
29
From large scale stainless steel to single-use and / or continuous processing or hybrid
30
range of demand
31
Production section - ‘engine technology’ Target for facility section Typical use Single use section Reducing investment cost Flexibility Clinical and Launch Changing production schedule Stainless steel section Reducing operation costs Increasing capacity Commercial supply Stable production scenarios
32
15,000 SS Bioreactor
(DSP) – less QA/QC work
DSP
8 times 2,000L SUS Bioreactors
buffer, UPS and DSP
15,000 L DSP 1 DSP 2 DSP 3 Bulk 8 x 2,000L DSP 1 DSP 2 DSP 3 Bulk
34
Concept
at “point of use”
stock solutions with water Advantages
Larger flexibility in meeting future volume requirements.
Challenges
Buffer prep. 1,000 L 10% salt Buffer hold 1,000 L 10% salt Optional conditioning 100L break tank Water 9 vol. 1 vol. Point of use Process equipment 1% salt Air gab 10 X buffers Buffer prep. 10.000L 1% salt Buffer hold 10.000L 1% salt Point of use Process equipment 1% salt Traditional
35
36
Modular – Copy / Paste
– same size and configuration Modular – off site construction of building elements – LEGO concept
pre-fabricated structures which are reassembled on-site.
and pre-tested at the factory prior to shipping Modular - PODular
is build and qualified off-site. The POD’s are then shipped to the site for the pharmaceutical production and connected to the stick built part of the facility
2 3 4 5 6
Air Handling
37
1 2 3 4 5 6
38
1 2 3 4 5 6
Air Handlin g
39
1 2 3 4 5
Façade - Adapted to local rules and building traditions. Technical support modules – HVAC etc. Technical distribution modules. Process area – Process and Support building modules. Foundations – for building modules and Technical distribution (water, drains, waste etc.)
40
41
42
Morten Munk Global Technology Partner NNE A/S mbmn@nne.com Mobile: +45 3079 2254